Laennec 50amg Pdrn Hair Growth Placenta Eliminate Wrinkles Menopause Syndrome Aging-Related

• Application: Face Body
• Disposable: Disposable
• Gender: Unisex
• Side Effect: No
• Usage: Injection
• Pharmaceutical Technology: Chemical Synthesis
• Model NO.: Laennec 50amg
• Efficacy: Anti Aging
• Transport Package: Aluminum Foil Bag, Bubblefil, Glass Bottleice Bag
• Specification: 2ml*50vials
• Trademark: Laennec 50amg
• Origin: Japa
• Production Capacity: 1000000 Boxes/Year

Product Description

Laennec is an ethical drug produced using JBP's unique technology that effectively extracts various cytokines and other physiologically active substances from the human placenta. The safety of our products is guaranteed by the strictest safety measures available in scientific standards.
Stimulates the body cells to rejuvenate the outer layers of the skin, such as wrinkles, dark spots and dark circles under the eyes, conditioning the skin. Leaves skin looking radiant and youthful. It stimulates blood circulation better. Therefore, stress can lower cholesterol while maintaining blood balance, which helps to restore the brain, lungs, liver, kidneys, and cardiovascular system. The system acts as a catalyst for growth. Repair damaged parts of the body, including muscle, skin collagen and bone tissue. The nervous system of the patient undergoing surgery. Menopause helps a woman's body recover faster and helps the body stay healthy and energetic. Women may be seen as suffering ones. It also helps relieve monthly aches and pains.

Regarding Medical Effects

As a result of clinical trials conducted throughout Japan,  positive effects on blood counts such as GOT and GPT were recognized - laennec was used in a number of liver and lung  diseases, showing high regeneration and recovery effects. Studies were conducted at 95% intervals,  for a more accurate effect,  placebo tests was applied to achieve more accurate results. Side effects identified during the tests include allergies  in 3.7% of patients. In less than one percent, itching and numbness were observed, but a clear connection between the injection and these symptoms has not been scientifically established. It is highly  not recommended to use the drug during lactation and pregnancy.

Dosage

In chronic recurrent herpes and atopic dermatitis, the drug is injected via IV:  10 ml (560 mg of placental hydrolyzate) of the medicine (5 vials) are dissolved in 250-500 ml of 5% dextrose solution or saline and injected through the ulnar vein for 1.5-2 h. Injections are carried out 3 times a week with an interval of 2 days. The course of treatment 10 injections.